Literature DB >> 17030904

Treatment of plague: promising alternatives to antibiotics.

Andrey P Anisimov1, Kingsley K Amoako2.   

Abstract

Plague still poses a significant threat to human health, and interest has been renewed recently in the possible use of Yersinia pestis as a biological weapon by terrorists. The septicaemic and pneumonic forms are always lethal if untreated. Attempts to treat this deadly disease date back to the era of global pandemics, when various methods were explored. The successful isolation of the plague pathogen led to the beginning of more scientific approaches to the treatment and cure of plague. This subsequently led to specific antibiotic prophylaxis and therapy for Y. pestis. The use of antibiotics such as tetracycline and streptomycin for the treatment of plague has been embraced by the World Health Organization Expert Committee on Plague as the 'gold standard' treatment. However, concerns regarding the development of antibiotic-resistant Y. pestis strains have led to the exploration of alternatives to antibiotics. Several investigators have looked into the use of alternatives, such as immunotherapy, non-pathogen-specific immunomodulatory therapy, phage therapy, bacteriocin therapy, and treatment with inhibitors of virulence factors. The alternative therapies reported in this review should be further investigated by comprehensive studies of their clinical application for the treatment of plague.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030904     DOI: 10.1099/jmm.0.46697-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  28 in total

1.  A novel post-exposure medical countermeasure L-97-1 improves survival and acute lung injury following intratracheal infection with Yersinia pestis.

Authors:  Constance N Wilson; Constance O Vance; Timothy M Doyle; David S Brink; George M Matuschak; Andrew J Lechner
Journal:  Innate Immun       Date:  2011-08-23       Impact factor: 2.680

2.  Identification of the lipopolysaccharide core of Yersinia pestis and Yersinia pseudotuberculosis as the receptor for bacteriophage φA1122.

Authors:  Saija Kiljunen; Neeta Datta; Svetlana V Dentovskaya; Andrey P Anisimov; Yuriy A Knirel; José A Bengoechea; Otto Holst; Mikael Skurnik
Journal:  J Bacteriol       Date:  2011-07-15       Impact factor: 3.490

3.  Outer membrane proteins ail and OmpF of Yersinia pestis are involved in the adsorption of T7-related bacteriophage Yep-phi.

Authors:  Xiangna Zhao; Yujun Cui; Yanfeng Yan; Zongmin Du; Yafang Tan; Huiying Yang; Yujing Bi; Pingping Zhang; Lei Zhou; Dongsheng Zhou; Yanping Han; Yajun Song; Xiaoyi Wang; Ruifu Yang
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

4.  Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model.

Authors:  Lynne K Garrity-Ryan; Oak K Kim; Joan-Miquel Balada-Llasat; Victoria J Bartlett; Atul K Verma; Michael L Fisher; Cynthia Castillo; Warangkhana Songsungthong; S Ken Tanaka; Stuart B Levy; Joan Mecsas; Michael N Alekshun
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

5.  Rapid and sensitive detection of Yersinia pestis using amplification of plague diagnostic bacteriophages monitored by real-time PCR.

Authors:  Kirill V Sergueev; Yunxiu He; Richard H Borschel; Mikeljon P Nikolich; Andrey A Filippov
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

6.  Broad-host-range Yersinia phage PY100: genome sequence, proteome analysis of virions, and DNA packaging strategy.

Authors:  Dominik Schwudke; Asgar Ergin; Kathrin Michael; Sven Volkmar; Bernd Appel; Dorothea Knabner; Antje Konietzny; Eckhard Strauch
Journal:  J Bacteriol       Date:  2007-10-26       Impact factor: 3.490

7.  Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.

Authors:  Philip A Arlen; Michael Singleton; Jeffrey J Adamovicz; Yi Ding; Abdolreza Davoodi-Semiromi; Henry Daniell
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

8.  Comparative genomics of the IncA/C multidrug resistance plasmid family.

Authors:  W Florian Fricke; Timothy J Welch; Patrick F McDermott; Mark K Mammel; J Eugene LeClerc; David G White; Thomas A Cebula; Jacques Ravel
Journal:  J Bacteriol       Date:  2009-05-29       Impact factor: 3.490

Review 9.  Plague: Recognition, Treatment, and Prevention.

Authors:  Ruifu Yang
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

Review 10.  Antibiotic Therapy of Plague: A Review.

Authors:  Florent Sebbane; Nadine Lemaître
Journal:  Biomolecules       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.